[(1S)-(1-(S)-N-Boc-氨基-2-环己基乙基)环氧乙烷 | 107202-62-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: [(1S)-(1-(S)-N-Boc-氨基-2-环己基乙基)环氧乙烷
• 英文名称: tert-butyl (S)-2-cyclohexyl-1-((S)-oxiran-2-yl)ethylcarbamate
• 英文别名: (S)-2-cyclohexyl-1-((S)-oxiran-2-yl)ethylcarbamate；tert-Butyl ((S)-2-cyclohexyl-1-((S)-oxiran-2-yl)ethyl)carbamate；tert-butyl N-[(1S)-2-cyclohexyl-1-[(2S)-oxiran-2-yl]ethyl]carbamate
• CAS: 107202-62-0
• 化学式: C₁₅H₂₇NO₃
• 分子量: 269.384
• InChiKey: JRMDRWOEBLIOTE-QWHCGFSZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  50.9
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  [(1S)-(1-(S)-N-Boc-氨基-2-环己基乙基)环氧乙烷 在 盐酸 、 sodium azide 、 氯化铵 、 三乙胺 作用下， 以 1,4-二氧六环 、 甲醇 、 乙腈 为溶剂， 反应 21.0h， 生成 3-((2S,3R)-4-azido-1-cyclohexyl-3-hydroxybutan-2-ylamino)-4-methoxycyclobut-3-ene-1,2-dione
  参考文献：
  名称：

  WO2007/117557

  摘要：

  公开号：
• 作为产物：
  描述：

  丁氧羰基--环乙基-丙氨酸-羟基盐酸盐 在 N-甲基吗啉 、 盐酸 、 氢氧化钾 、 sodium tetrahydroborate 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 乙醚 、 乙醇 、 水 为溶剂， 反应 5.58h， 生成 [(1S)-(1-(S)-N-Boc-氨基-2-环己基乙基)环氧乙烷
  参考文献：
  名称：

  Amino Diol HIV Protease Inhibitors. 1. Design, Synthesis, and Preliminary SAR

  摘要：

  A series of HIV protease inhibitors containing a novel C-2 symmetrical ''aminodiol'' core structure were prepared from amino acid starting materials. The ability of the aminodiols to inhibit HIV replication in cell culture is comparable to their ability to inhibit the isolated enzyme, a result compatible with good cell membrane penetration by this class of compounds. Optimization of the structure-activity in this series led to aminodiol 9a (K-i = 100 nM; ED(50) (HIV-1) = 80 nM) containing P-1/P-1', benzyl and P-2/P-2' Boc substituents. Compound 9a is a selective inhibitor of HIV protease versus other aspartyl proteases such as human renin, human cathepsin D, and porcine pepsin. In addition, 9a is equipotent against HIV-1 and HIV-2 in cell culture and demonstrates similar activity in infected T-lymphocytes and PBMCs. After iv and oral administration in rats, 9a displayed significant oral bioavailability (ca. 40%) and a promising plasma elimination half-life (4 h).

  DOI：

  10.1021/jm00038a005

文献信息

• Synthesis of chiral iodo-N,O-acetonide aminal scaffolds via an efficient cascade reaction of amino acid-derived epoxides
  作者：J. Paige Souder、Zachary M. Evans、Joshua A. Driver、Eric J. Pozzo、Andrew J. Lampkins

  DOI：10.1016/j.tetlet.2011.10.049

  日期：2011.12

  Novel amino acid-derived iodo-N,O-acetonide aminals were developed as chiral, non-epimerizable scaffolds to facilitate complex molecule synthesis. These scaffolds are readily prepared from commercially available amino acid derivatives in ⩽6 steps, contain an orthogonally-protected β-hydroxy amine moiety, and feature a directly reactive alkyl-iodide group for facile substitution chemistry. Further,

  新型氨基酸衍生的碘-N，O-丙酮化物缩醛被开发为手性，不可表麻的支架，以促进复杂分子的合成。这些支架可通过⩽6步骤轻松地从市售氨基酸衍生物制备，包含正交保护的β-羟基胺部分，并具有直接反应性的烷基碘基团，可轻松实现取代化学。此外，开发了一种新颖的开环/环化级联反应，可以从容易获得的环氧化物衍生物中高效制备这些化合物（59-72％）。
• A convenient, stereodivergent approach to the enantioselective synthesis of N-Boc-aminoalkyl epoxides
  作者：Patricia Castejón、Mireia Pastó、Albert Moyano、Miquel A Pericàs、Antoni Riera

  DOI：10.1016/0040-4039(95)00415-9

  日期：1995.4

  An efficient, stereodivergent and enantioselective synthesis of N-Boc-aminoalkyl epoxides has been developed. Starting from enantiomerically enriched antiN-diphenylmethyl-3-amino-1,2-diols, and after a change in the nitrogen protecting group, an intramolecular Mitsunobu reaction leads to the erythro aminoalkyl epoxides; a three step sequence consisting of protection of the primary alcohol, activation

  已经开发了N - Boc-氨基烷基环氧化物的有效，立体发散和对映选择性的合成。从对映异构体富集的抗N-二苯基甲基-3-氨基-1,2-二醇开始，并在改变氮保护基团之后，分子内的Mitsunobu反应导致赤型氨基烷基环氧化物；由伯醇的保护，仲醇的活化和同时的脱保护/环化组成的三个步骤序列以良好的产率提供了相应的苏式异构体。
• N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
  申请人：——

  公开号：US20040171881A1

  公开（公告）日：2004-09-02

  Disclosed are compounds of the formula 1 wherein the variables R N , R C , R 1 , R 25 , R 2 , and R 3 are as defined herein. These compounds have activity as inhibitors of beta-secretase and are therefore useful in treating a variety of discorders such as Alzheimer's Disease.

  本文披露了式1的化合物，其中变量RN、RC、R1、R25、R2和R3的定义如本文所述。这些化合物具有抑制β-分泌酶的活性，因此可用于治疗多种疾病，如阿尔茨海默病。
• Diaminoalkane Aspartic Protease Inhibitors
  申请人：Baldwin John J.

  公开号：US20090018103A1

  公开（公告）日：2009-01-15

  Diaminoalkanes of Formula I have now been found which are orally active and bind to aspartic proteases to inhibit their activity. They are useful in the treatment or amelioration of diseases associated with elevated levels of aspartic protease activity. The invention also relates to a method for the use of the compounds of Formula I in ameliorating or treating aspartic protease related disorders in a subject in need thereof comprising administering to said subject an effective amount of a compound of Formula I.

  公式I的Diaminoalkanes现已被发现，它们具有口服活性并结合到天冬氨酸蛋白酶以抑制其活性。它们在治疗或改善与天冬氨酸蛋白酶活性升高相关的疾病方面非常有用。本发明还涉及使用公式I化合物治疗或改善需要的天冬氨酸蛋白酶相关疾病的方法，包括向该受体施用公式I化合物的有效量。
• N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
  申请人：Elan Pharmaceuticals, Inc.

  公开号：US07176242B2

  公开（公告）日：2007-02-13

  Disclosed are compounds of the formula wherein the variables RN, RC, R1, R25, R2, and R3 are as defined herein. These compounds have activity as inhibitors of beta-secretase and are therefore useful in treating a variety of discorders such as Alzheimer's Disease.

  本发明涉及一种式子如下的化合物，其中变量RN、RC、R1、R25、R2和R3的定义如下。这些化合物具有作为β-分泌酶抑制剂的活性，因此在治疗多种疾病，如阿尔茨海默病方面有用。